Avista Healthcare Public Acquisition Corp.Units
AHPAU
AHPAU was delisted on the 30th of October, 2018.
5 hedge funds and large institutions have $25.9M invested in Avista Healthcare Public Acquisition Corp.Units in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
29% less funds holding
Funds holding: 7 → 5 (-2)
48% less capital invested
Capital invested by funds: $49.3M → $25.9M (-$23.4M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$20.6M |
| 2 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
-$2.74M |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$7.23K |
AHPAU Hedge Fund Activity: Q4 2017 in Review
5 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Avista Healthcare Public Acquisition Corp.Units (AHPAU) for Q4 2017, worth a combined $25.9M — down 48% from $49.3M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of AHPAU and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was ArrowMark Colorado Holdings, exiting entirely with an estimated $20.6M sold.
- 5 institutional investors held Avista Healthcare Public Acquisition Corp.Units (AHPAU) as of Q4 2017, down from 7 in Q3 2017.
- Funds reported $25.9M of Avista Healthcare Public Acquisition Corp.Units stock for Q4 2017, down 48% quarter-over-quarter.
- 0 funds opened new Avista Healthcare Public Acquisition Corp.Units positions in Q4 2017 and 2 closed out, a net change of -2 holders.
- The largest Avista Healthcare Public Acquisition Corp.Units seller in Q4 2017 was ArrowMark Colorado Holdings, an estimated $20.6M sold.
Based on aggregated 13F filings for Q4 2017.